Clinical Trials Directory

Trials / Terminated

TerminatedNCT05925400

Interest of Virtual Reality in the Management of Anxiety and Pain During Embryo Transfer (ET)

Effect of Virtual Reality On IN-Vitro fEcuNdation ouTcomes: a Randomized Controlled Trial (VR-INVENT)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
CMC Ambroise Paré · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers
Not accepted

Summary

This study compares the use of virtual Reality versus the usual service protocol for the management of anxiety and pain related to In-Vitro fertilization (IVF) procedure

Detailed description

Medical interventions often cause pain, distress or anxiety for most patients. The use of music and movies has proven effective in pediatrics. Virtual Reality (VR) is a newer technology that immerses users in a pleasant, three-dimensional environment via a headset. By distracting patients, this technology can reduce anxiety, discomfort and ultimately pain associated with care. This randomized monocentric trial compares the effect of the use of VR versus without VR during the transfer of a fresh blastocyst on the 5th day of development OR a frozen embryo on the 5th day of development. The primary outcome will include clinical pregnancy rate and the secondary outcome focuses on the patient's levels of anxiety and stress. Data on the level of anxiety and stress will be collected through questionnaires before and after the procedure. Also, clinical pregnancy, defined by the presence of one or more gestational sacs with one or more embryos showing cardiac activity, will be assessed through ultrasons 8 ± 4 weeks after the procedure

Conditions

Interventions

TypeNameDescription
DEVICEVirtual Reality during Embryo TransferPatients randomized to the study group, will be provided with the VR headset. The VR exposure will take place 10-15 minutes before the Embryo Transfer (ET) and a 10 min immersion after the ET

Timeline

Start date
2023-11-15
Primary completion
2025-07-16
Completion
2025-07-16
First posted
2023-06-29
Last updated
2025-08-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05925400. Inclusion in this directory is not an endorsement.